Thanks for sharing, to be fair though as a revenue generating business it's pretty easy to come up with a valuation. Just take the revenue ($28m run rate probably the best figure to use) and apply a typical multiple for a high growth rate company and you'll get between 50c - $1 as a conservative estimate (similar to what he came up with). Would be keen to know the exact methodology he used though as there are certainly a few methods that can be used here to find the fair value, and for a company like this you really want to use a method that focuses more on predicting future revenues and cashflows, than one that simply looks at the current revenue
- Forums
- ASX - By Stock
- CMS Proposes Major Increase in Reimbursement for Canaloplasty
Thanks for sharing, to be fair though as a revenue generating...
-
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EYE (ASX) to my watchlist
|
|||||
Last
21.3¢ |
Change
-0.008(3.41%) |
Mkt cap ! $48.67M |
Open | High | Low | Value | Volume |
22.5¢ | 22.5¢ | 21.0¢ | $50.23K | 232.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 400905 | 21.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
21.5¢ | 63286 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 400905 | 0.210 |
6 | 114936 | 0.205 |
14 | 180879 | 0.200 |
1 | 5000 | 0.195 |
1 | 27027 | 0.185 |
Price($) | Vol. | No. |
---|---|---|
0.215 | 63286 | 3 |
0.220 | 28955 | 2 |
0.230 | 50000 | 1 |
0.235 | 5645 | 1 |
0.250 | 200000 | 3 |
Last trade - 13.15pm 13/08/2024 (20 minute delay) ? |
Featured News
EYE (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online